Research interests
Atherosclerosis and vascular receptor biology[6]
NJ
Neil J. Freedman
As of 2026 · Last known relationship
As of 2026 · Last known relationship
Neil J. Freedman is a Duke University cardiologist and faculty researcher whose work connects vascular receptor biology with the mechanisms of atherosclerosis and heart disease. He is listed as Professor of Medicine and Professor in Cell Biology at Duke, with research focused on atherosclerosis-related signal transduction, receptor protein tyrosine kinases, G protein-coupled receptor kinases, β-arrestins, and vascular smooth muscle and endothelial biology. His research also addresses genetic mechanisms of atherosclerosis, vein graft failure, and neointimal hyperplasia. Freedman earned an M.D. from Harvard Medical School in 1985, completed medicine residency at Beth Israel Hospital from 1985 to 1988, pursued research training at Brigham and Women’s Hospital and MIT, and completed cardiology fellowship at Duke from 1990 to 1993. He has also taught EKG interpretation and reading in Duke residency programming.
Each topic is linked to its supporting source in Sources.
Training includes Research Principal Investigator for an NHLBI-awarded project on mechanisms by which small nucleolar RNAs exacerbate atherosclerosis, Lectured on EKG interpretation, Associate Professor of Medicine at Duke University, and Assistant Professor in Cell Biology at Duke University, plus 18 more records.
Explore education and trainingAs of 2026
As of 2017
As of 2017
As of 2017
As of 2016
As of 2006
As of 1996
As of 1993
As of 1993
As of 1990
As of 1990
As of 1990
As of 1989
As of 1988
As of 1988
As of 1985
As of 1985
As of 2017
As of 2017
As of 2017
As of 2017
Atherosclerosis and vascular receptor biology[6]
Atherosclerosis-related signal transduction and the genetic bases of atherosclerosis and vein graft failure[12]
Research concerning anti-beta1-adrenergic receptor antibodies and heart failure[13]